Home Library of tools Data Guidance Framework info Other resources Platforms Regulation About us

Library of tools

Tools description

This tool is designed to construct nano-specific species sensitivity distributions (SSD) used in environmental hazard assessment. The nano-specific Species Sensitivity Weighted Distribution (nSSWD) can be accessed as part in the SUN Decision Support System (SUNDS). The approach is based on three species weighting criteria (i.e. species relevance, trophic level abundance and data quality) as well as weighting factors for data quality and the extent of physico-chemical characterisation of the tested nanomaterial in each study. SSD curves are calculated for hazard concentrations (HCx) for 5%, 50% and 95% of species.

SimpleBox4nano is a regulatory-relevant multimedia environmental fate model that is specifically fit for use with nanomaterials. The tool predicts background concentrations of nanomaterials in air, water, sediment and soil. SimpleBox4Nano does so by simultaneously solving mass balance equations for each environmental compartment box in the model. It is a first-principles model in the sense that it internally derives mass flow rates from physical and chemical substance properties, and characteristics of the environment modeled. It takes user-specified release rates as input, producing exposure concentrations in the environment as output.

The SUNDS web tool covers risk management and sustainability of nano-enabled products along their life cycle. It is based on a tiered approach including a decision support tool and a risk assessment and control part. It is based on REACH guidelines and focuses on assessment models. Besides traditional risk assessment and risk management information, the system also asks for the inclusion of sustainability data supporting safer-by-design nano-enabled products (this includes life cycle assessment, social and economic impact assessments). The tool covers human and environmental exposure, hazard and risk assessment.

The LICARA Tool supports SMEs in their decision-making process. It does this by scanning both the benefits and risks over the nanoproduct's life time. It uses a structured life cycle approach which enables the evaluation of the benefits and risks qualitatively with low and manageable efforts, over the nanoproduct's life time. It further allows a comparison with the risks and benefits of the conventional (non-nano) products. The tool stimulates economic, environmental and social opportunities. This tool is specifically intended for use by SMEs to support them in communicating with regulators, and potential clients and investors.

The precautionary matrix for synthetic nanomaterials is geared toward industry and trade. The precautionary matrix is a method for assessing the nano-specific health and environmental risks of nanoproducts. The precautionary matrix enables the structured assessment of the “nano-specific need for precautions” when handling synthetic nanomaterials. The precautionary matrix is designed to help industry and trade comply with their due diligence and their duty to exercise self-control opposite employees, consumers and the environment.

GUIDEnano is a risk assessment model that allows the assessment and mitigation of human and environmental risks related to nanomaterials and nano-enabled product, considering their whole life cycle. Using the GUIDEnano Tool, different stakeholders can evaluate and efficiently mitigate possible health risks for workers, consumers and the environment.

The ConsExpo nano tool can be used to estimate inhalation exposure to nanomaterials in consumer spray products. To run the model, user input on different exposure determinants such as the product and its use, the nanomaterial and the environmental conditions is required. Exposure is presented in different measures. The outcome of the assessment is an alveolar load in the lungs as one of the most critical determinants of inflammation of the lungs is both the magnitude and duration of the alveolar load of a nanomaterial. To estimate the alveolar load arising from the use of nano-enabled spray products, ConsExpo nano combines models that estimate the external aerosol concentration in indoor air, with models that estimate the deposition in and clearance of inhaled aerosol from the alveolar region.

This module allows you to qualitatively assess occupational health risks from inhalation exposure to manufactured nanomaterials. Risk management measures may be selected or included in the action plan. “Stoffenmanager Nano” is an extension of Stoffenmanager, which is a knowledge-based platform aimed at reducing exposure risks to hazardous substances and biological agents in the workplace.

NanoSafer is a combined control-banding and risk management tool that enables assessment of the risk level and recommended exposure control associated with production and use of manufactured nanomaterials (e.g., nanoparticles, nanoflakes, nanofibers, and nanotubes) in specific work scenarios. In addition to manufactured nanomaterials, the tool can also be used to assess and manage emissions from nanoparticle-forming processes.

RISKOFDERM is a quantitative model for estimating potential dermal exposure, i.e. the total amount of a substance coming into contact with the protective clothing, work clothing and exposed skin. It includes six dermal exposure operation (DEO) units, where each unit is a cluster of exposure scenarios involving general chemical substances. In the context of nanomaterials, its applicability domain is not yet established. In the present study, the performance of the model, while estimating the dermal exposure to nanomaterials, is tested by comparing its output with experimentally measured dermal exposure levels of nanomaterials on hands.

The Safety Observer app template 'NanoObserver' can be used in measuring safe and healthy working conditions and behaviour with nanomaterials. A template for the free smartphone/tablet app ‘Safety Observer’ has been developed for use in proactive safety rounds in industrial and academic workplaces that work with or are exposed to manufactured nanomaterials (MN). The template can be adapted to a local context and language, and be used by students, workers, faculty, managers and OSH professionals. Safe and unsafe working conditions and behaviour regarding MN in a workplace are observed and counted, such as: 1) MN signage, marking and labelling 2) MN handling, storage and transport 3) Ventilation and filters 4) Personal protective equipment 5) Technical aids 6) Order and tidiness 7) Hygiene 8) Waste storage, recycling and disposal 9) First aid equipment. Comments and photos can be included in the observations with the app, and a final report, including a ‘safety index’, is automatically generated and made available in the app and sent to one’s email for immediate use in improving and reinforcing OSH initiatives.

The approach is specifically applicable to similarity assessment as a basis for grouping of (nanoforms of) chemical substances as well as for classification of the substances according to the Classification, Labeling and Packaging regulation. The unique goal of this approach is to assess data quality in such a way that all the steps are automatized, thus reducing reliance on expert judgment. The analysis starts from available (meta)data as provided in the data entry templates developed by the NanoSafety community and used for import into the eNanoMapper database. The methodology is implemented in the templates as a traffic light system—the providers of the data can see in real time the completeness scores calculated by the system for their datasets in green, yellow, or red.

This online tool provides estimates of indoor exposure to airborne particles and is based on the NIST multizone modeling software, CONTAM. It is couple with a size resolved tool, which is an additional physical model that accounts for the properties of nanoparticles that may impact their transport within the built environment including some beyond those that CONTAM is currently capable of modeling, e.g., coagulation.

The BIORIMADS uses advanced models to support the occupational, consumer and environmental risk assessment of nanomaterials and biomaterials along the lifecycle of nano-enabled consumer products and medical applications. The BIORIMADS addresses nano and biomaterials used in medical applications such as medical devices and advanced therapy medicinal products (ATMPs). In situations where the risks are not controlled the BIORIMADS proposes suitable Risk Management Measures (e.g. engineering controls, Personal Protective Equipment) and provides information about the cost of implementing these measures. Risk control can be demonstrated by reducing risk to below threshold levels or by investigating feasible alternatives to the substance. If the risks cannot be adequately controlled and no feasible alternatives can be found, a Socioeconomic Analysis (SEA) can be performed to demonstrate that the benefits of using a certain nano/biomaterial or application significantly outweigh the risks.

The combined dosimetry model (CoDo) can be used to simulate the exposure concentrations in air corresponding to the doses used in in vitro studies in submerged systems. It works by integrating in vitro dosimetry and lung dosimetry, and assuming that the deposited dose per area in vitro corresponds to the deposited dose per area in the lung. The input data include experimental parameters about the in vitro system and lung parameters that define the hypothetical human exposure scenario; the required parameters and the parameters that, if not specified by the user, are calculated by the model.

The nano Benefit Assessment Matrix (nano-BAM) supports the assessment of functional, health and environmental benefits of nanomaterials, nano-enabled manufactured nanomaterials and products from the first innovation stage until the product is on the market. The BAM assists users to summarize the benefits by assessing two aspects: (i) Degree of benefit (DoB) to estimate how achievable the benefits are and (ii) Degree of evidence (DoE) to understand what scientific evidence is available for the benefit identified by users.

The “Socio-Economic Life Cycle-Based Framework for SSbD” is a tool to perform a socio-economic assessment of nanomaterials and nano-enabled products to support decision-making for safe-and sustainable-by-design (SSbD). The main target user group is industries in the early stages of product development. The framework, based on a social life cycle analysis (S-LCA) and multi-criteria decision analysis (MCDA) methodologies, will help users make decisions that would reduce the negative socio-economic impacts of nanomaterials and nano-enabled products.

Dynamic Probabilistic Material Flow analysis (DPMFA) can be used to predict release of nanomaterials to the environment based on an analysis of the mass flows during the full life cycle from nanomaterial production over use to final end-of-life treatment of nanoenabled products. Main input requirements are data about production amounts, uses in products and transfer coefficients between all compartments, e.g. release or behavior during EoL. The model then quantifies flows into environmental compartments such as water, air, soil and the subsurface. These flows can then be used as input for environmental fate models.

NanoDUFLOW is a nanomaterial environmental fate model that links nanomaterial-specific process descriptions to a spatially explicit hydrological model. The link enables the realistic modelling of feedbacks between local flow conditions and nanomaterial fate processes, such as homo- and heteroaggregation, resuspension and sedimentation. Spatially explicit simulations using five size classes of engineered nanomaterials and five size classes of natural solids showed how nanomaterial sediment contamination ‘hot spots’ and nanomaterial speciation can be predicted as a function of place and time.

ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration. NanoApp helps registrants follow the European Chemical Agency (ECHA)’s new registration requirements for nanomaterials under the EU’s REACH legislation. It does this by creating and justifying ‘sets of similar nanoforms’ for a joint human health and environmental hazard, exposure and safety assessment. The tool uses established criteria and rules that systematically evaluate similarity between nanoforms. On that basis, it concludes whether a set of nanoforms can be justified or not. Its decision logic follows the ECHA guidance in a transparent and evidence-based manner – covering primarily the ‘Appendix for nanoforms applicable to the Guidance on Registration and Substance Identification’.

The model is very useful for the exposure assessment of products containing nanomaterials during shredding (end-of-life), a part of the life cycle where there is little data available. With a Bayesian probabilistic nature in its core, it uses subjective judgement when data is unavailable or scarce while being able to adapt and update risk forecasts as new information becomes available. Its novelty lies on a simplistic approach which combines the material and process variables of the system to determine the probability of number, size, mass and composition of released particles. It is applicable to the shredding of a wide range of nano-enabled products and it aims to reduce the nanomaterial release by using the safe(r)-by-design approach.

Tool to assess risks associated with nanotechnology operations. The tool estimates an emission probability and severity band and provides advice on what engineering controls to use. It includes nine domains covering handling of liquids, powders and abrasion of solids. Combines hazard “severity” scores and exposure “probability” scores in a matrix to obtain a level of risk and associated controls out of 4 possible levels of increasing risk and associated controls. Control banding (CB) strategies (a qualitative risk characterization and management strategy) offer simplified solutions for controlling worker exposures to constituents that are found in the workplace in the absence of firm toxicological and exposure data.

This framework allows to quantify the readiness of different tools and methods towards their wider regulatory acceptance and downstream use by different stakeholders. The framework diagnoses barriers which hinder regulatory acceptance and wider usability of a tool/method based on their Transparency, Reliability, Accessibility, Applicability and Completeness (TRAAC framework). Each TRAAC pillar consists of criteria which help in evaluating the overall quality of the tools and methods for their (i) compatibility with regulatory frameworks and, (ii) usefulness and usability for end-users, through a calculated TRAAC score based on the assessment. Fourteen tools and methods were assessed using the TRAAC framework as proof-of-concept. The results provide insights into any gaps, opportunities, and challenges in the context of each of the 5 pillars of the TRAAC framework.

The Screening Multiple Criteria Decision Analysis (SMCDA) was developed to rank different material options (not only nanomaterials) according to their acceptability in terms of broader environmental and socioeconomic aspects. The criteria used in SMCDA relate to properties of the material that are specific to the production, use, and end-of-life phases. Its structure aims to provide initial guidance even without the knowledge and resources required for a full life cycle analysis. The input questionnaire is divided into three levels that unfold with the user's experience. SMCDA applies weighting to consider the varying relevance of criteria and to improve differentiation among comparable alternatives. The probabilistic approach accounts for uncertainty and missing knowledge. An analysis requires only semi-quantitative estimates without the need for exact numbers, and results can be obtained even with incomplete inputs. SMCDA is intended to be used by various societal actors to contribute to processes of reflexive innovation.

This is a stochastic probabilistic long-term risk prediction tool (working at its best for up to 100 years and more) targeting product material (ingredient) interaction between product life phases and a variety of media and environments. This tool is not mass-flow oriented but builds on probabilistic predictions of the target material's (product ingredient's) location and transformation over its lifecycle and beyond. It performs without predefined (theoretical and other) probability distributions but generates them itself. Its computations integrate humans and environments' risk and vulnerability by combining the load contamination of potential pollutants with toxicity and ecotoxicity data. This tool aims to predict and target specific product ingredients, including newly engineered nanomaterials and their lifecycle-long (up to 50 years) location in and migration through environmental (human) and technical systems. The target compartments and organisms potentially vulnerable or at risk are air, freshwaters, marine waters, groundwater, saline groundwater, freshwater sediments, marine water sediments, soils, freshwater flora, marine water flora, freshwater fauna, marine water fauna and child and adult humans. PERST's services may be used in target regions covering all EU member states, Switzerland and the UK. The main PERST-output forms are 3D graphics with probabilistic information for long time periods, boxplots summarising these outputs distributions over time and line charts visualising the evolution of the target outputs. A product risk etiquette is under construction for evaluating the total risks computed for a target product (product ingredient). More from this info can be found on https://www.etss.ch/perst/.

This tool is based on the bow-tie model and has been adapted for the the specifics of nanotechnology related risk. The bow-tie model offers a paradigm of engagement across an extended temporal plane as it seeks to engage the risk management function within the insurance industry with mitigation and control measure in the ex-ante phase of analysis. The bow-tie model offers a number of advantages. The fact it is visually represented allows for improved heuristics and this is combined with its ability to deliver quite precise risk metrics. Importantly, for a field such as nanotechnology, the model is open to iterative improvement as more data or more precise probabilistic analysis becomes available. the bow-tie model could be used in conjunction with other methodologies and its adoption in no way precludes the use of other approaches such as control banding. The fact that it is a well understood process by insurers and indeed those in the chemical industry leads us to believe that at this stage it is the best candidate tool or perhaps best method available at this juncture

Tools to support Life Cycle Impact Assessment

ReCiPe is an impact assessment method within LCA and calculates 18 midpoint indicators and 3 endpoint indicators. Human Toxicity (cancer and non cancer) and Ecotoxicity (terrestrial, marine and freshwater) are included among the impact categories evaluated, but the method has not been adapted to model nanomaterials specifically. The characterization factor of human toxicity and ecotoxicity accounts for the environmental persistence (fate), accumulation in the human food chain (exposure), and toxicity (effect) of a chemical.

USEtox is a model providing midpoint and endpoint characterization factors for human toxicological and freshwater ecotoxicological impacts of emissions in life cycle assessment. Characterization factors are calculated in three steps:

-Environmental fate, modelling the distribution and degradation of substances,

-Exposure, where the exposure of humans, animals and plants is modelled,

-Effects, where the inherent damage of the substance is modelled.

The method has not been adapted to model nanomaterials, but approaches have been proposed to combine USEtox damage and exposure assessment with SimpleBox4nno fate assessment (Salieri et al. 2019).



LCA Software, enabling ISO 14044 compliance

SimaPro is a professional LCA software tool that enables modelling and analysing complex life cycles in a systematic and transparent way.

In the data collection stage, the user can input the amount of material, processes and relative data available in the large databases built in the package, which are collected from a large number of sources related to a variety of assessment methods. The database can be modified and extended based on the customer's requirement. Using its customizable parameters and Monte Carlo analytical capabilities, SimaPro can determine the potential environmental impact that a system or service produces with statistical accuracy. The use of parameters provides flexibility to easily change values or assumptions, which facilitates sensitivity analyses (switching between values), scenario analyses (specify a range of values for a parameter), and defining non-linear relationships.

Gabi 6 is a well-recognised software tool for modelling products and systems from a life cycle perspective. Within GaBi software processes are modelled in the GaBi Plan editor, feeding them with data sets from the GaBi and Ecoinvent databases. On GaBi plans, individual elements of a product or the product life cycle are combined into an overall model using unit processes. Advanced parametrization options are available in order to define variables and dependencies in the model, which can be used to model scenarios.GaBi software provides a wide set of databases. On the other hand, GaBi software provides options to customize reports and export them.

The Umberto LCA software tool is a very flexible and powerful software tool for modelling, calculating, visualizing, and evaluating material and energy flows. It is based on the so-called Petri networks, a special type of network from theoretical informatics which, with its strict systematic, not only allows the setup of complex systems but also a combined material and inventory calculation. The tool enables parametrization and scenario modelling, To facilitate this assessment, easy integration of existing primary data (e.g. by linking Microsoft Excel cell values with Umberto model) is possible. The tool can also integrate the two market leaders databases, Ecoinvent and GaBi.

OpenLCA is a free, open source LCA software. The software does not have a built-in database, but free and for purchase databases can be found on the dedicated website https://nexus.openlca.org/. Moreover, the user can import their own data in a wide range of formats, such as EcoSpold 01 and 02, and ILCD, thanks to the built-in implementation of the format converter functionalities. OpenLCA supports the use of parameters, the calculation of uncertainty via Monte Carlo simulations, and sensitivity analysis.


Tools list

Model/tool Owner of the tool Nanospecific
Type of tool
Application domain
Applicable roots of release and exposure
Applicable R&I phase
Cooper stage-gate
Applicable population
Applicable products with EU regulations
Applicable material
Difficulty
Tool output
Short description of tool and references
Stoffenmanager NanoCosanta BV1. Yes1. Control banding3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase4. R&D2. Worker1. Chemical substances1. Powdered spherical particulate1. 1-1.92. Semi-quantitativehttps://nano.stoffenmanager.com/Default.aspx?lang=en
Stoffenmanager Nano2. Market phase2. Cosmetic products2. Powdered non-spherical particulate
Stoffenmanager Nano3. Medical devices3. Liquid dispersion
Stoffenmanager Nano4. Biocides4. Solid reinforced composite
Stoffenmanager Nano5. Food contact materials
Stoffenmanager Nano6. Food labelling
Stoffenmanager Nano7. Drugs
Nanosafer CBNRCWE1. Yes1. Control banding3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase1. Idea2. Worker1. Chemical substances1. Powdered spherical particulate1. 1-1.92. Semi-quantitativehttp://www.nanosafer.org/
Nanosafer CB5. Numerical estimate2. Screening2. Cosmetic products2. Powdered non-spherical particulate
Nanosafer CB3. Buisness case3. Medical devices
Nanosafer CB4. R&D4. Biocides
Nanosafer CB5. validation5. Food contact materials
Nanosafer CB6. Launch6. Food labelling
Nanosafer CB7. Monitoring7. Drugs
GUIDEnanoLEITAT1. Yes5. Numerical estimate3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase2. Screening1. Environment1. Chemical substances1. Powdered spherical particulate1. 1-1.93. Quantitativehttps://tool.guidenano.eu/Home/About
GUIDEnano2. Market phase3. Buisness case2. Worker2. Cosmetic products2. Powdered non-spherical particulate
GUIDEnano4. R&D3. Consumer3. Medical devices3. Liquid dispersion
GUIDEnano5. validation4. General population4. Biocides4. Solid reinforced composite
GUIDEnano6. Launch5. Food contact materials
GUIDEnano7. Monitoring6. Food labelling
GUIDEnano7. Drugs
RiskofDermTNO2. No5. Numerical estimate1. Release/exposure assessment2. Dermal only1. Design phase1. Idea2. Worker1. Chemical substances1. Powdered spherical particulate1. 1-1.93. Quantitativehttps://www.eurofins.com/media/2245/dermal_toolkit_paper_version-en.pdf
RiskofDerm2. Market phase2. Screening4. Biocides2. Powdered non-spherical particulate
RiskofDerm3. Regulatory phase3. Buisness case
RiskofDerm4. R&D
RiskofDerm5. validation
RiskofDerm6. Launch
RiskofDerm7. Monitoring3. Liquid dispersion
LICARA nanoSCANTNO/EMPA1. Yes2. Risk Screening3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase1. Idea1. Environment1. Chemical substances1. Powdered spherical particulate1. 1-1.91. Qualitativehttp://publicationslist.org/data/nowack/ref-160/2014_09_29_Licara%20Guidelines_m_links[1].pdf
LICARA nanoSCAN3. Life cycle assessment4. Risk-benefit analysis2. Screening2. Worker2. Cosmetic products2. Powdered non-spherical particulate
LICARA nanoSCAN3. Buisness case3. Consumer3. Liquid dispersion
LICARA nanoSCAN4. General population4. Biocides4. Solid reinforced composite
LICARA nanoSCAN
LICARA nanoSCAN
LICARA nanoSCAN
Swiss precautionary matrix Swiss Federal Office of Public Health1. Yes2. Risk Screening1. Release/exposure assessment4. All routes1. Design phase3. Buisness case1. Environment1. Chemical substances1. Powdered spherical particulate1. 1-1.91. Qualitativehttps://www.bag.admin.ch/bag/en/home/gesund-leben/umwelt-und-gesundheit/chemikalien/nanotechnologie/sicherer-umgang-mit-nanomaterialien/vorsorgeraster-nanomaterialien-downloadversion.html
Swiss precautionary matrix 3. Life cycle assessment2. Hazard assessment4. R&D2. Worker2. Cosmetic products2. Powdered non-spherical particulate
Swiss precautionary matrix 5. validation3. Consumer3. Medical devices3. Liquid dispersion
Swiss precautionary matrix 6. Launch4. Biocides4. Solid reinforced composite
Swiss precautionary matrix 7. Monitoring5. Food contact materials
Swiss precautionary matrix 6. Food labelling
Swiss precautionary matrix 7. Drugs
Control Banding NanotoolLawrence Livermore National Laboratory1. Yes1. Control banding3. Risk assessment (hazard and exposure)4. All routes1. Design phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A1. Qualitativehttps://controlbanding.llnl.gov/
Control Banding Nanotool2. Cosmetic products2. Powdered non-spherical particulate
Control Banding Nanotool3. Medical devices3. Liquid dispersion
Control Banding Nanotool4. Biocides4. Solid reinforced composite
Control Banding Nanotool5. Food contact materials
Control Banding Nanotool6. Food labelling
Control Banding Nanotool7. Drugs
DeRmal Exposure Assessment Method (DREAM)TNO2. No2. Risk Screening1. Release/exposure assessment2. Dermal only1. Design phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A2. Semi-quantitativehttps://academic.oup.com/annweh/article/47/1/71/131394
DeRmal Exposure Assessment Method (DREAM)2. Market phase2. Cosmetic products2. Powdered non-spherical particulate
DeRmal Exposure Assessment Method (DREAM)3. Medical devices3. Liquid dispersionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1741090/
DeRmal Exposure Assessment Method (DREAM)4. Biocides
DeRmal Exposure Assessment Method (DREAM)5. Food contact materials
DeRmal Exposure Assessment Method (DREAM)6. Food labelling
DeRmal Exposure Assessment Method (DREAM)7. Drugs
DeRmal Exposure Assessment Method (DREAM)
ECETOC TRAECETOC2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A2. Semi-quantitativehttp://www.ecetoc.org/tools/targeted-risk-assessment-tra/
ECETOC TRA2. Dermal only2. Market phase2. Worker2. Cosmetic products2. Powdered non-spherical particulate
ECETOC TRA3. Regulatory phase3. Consumer3. Medical devices3. Liquid dispersion
ECETOC TRA4. Biocides4. Solid reinforced composite
ECETOC TRA5. Food contact materials
ECETOC TRA6. Food labelling
ECETOC TRA7. Drugs
Consexpo Nano ToolRIVM1. Yes5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Screening3. Consumer1. Chemical substances3. Liquid dispersion1. 1-1.93. Quantitativehttps://www.rivm.nl/en/consexpo/related-tools/nano-tool/about
Consexpo Nano Tool3. Buisness case
Consexpo Nano Tool4. R&D
Consexpo Nano Tool5. validation
Consexpo Nano Tool6. Launch
Consexpo Nano Tool7. Monitoring4. Biocides
Advanced REACH Tool (ART)HSL2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Screening2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.advancedreachtool.com/
Advanced REACH Tool (ART)2. Market phase3. Buisness case2. Cosmetic products2. Powdered non-spherical particulate
Advanced REACH Tool (ART)3. Regulatory phase4. R&D3. Medical devices3. Liquid dispersion
Advanced REACH Tool (ART)5. validation4. Biocides4. Solid reinforced composite
Advanced REACH Tool (ART)6. Launch5. Food contact materials
Advanced REACH Tool (ART)7. Monitoring6. Food labelling
Advanced REACH Tool (ART)7. Drugs
Advanced REACH Tool (ART)
SprayExpo model BAUA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Screening2. Worker1. Chemical substances3. Liquid dispersion6. N/A3. Quantitativehttps://www.baua.de/EN/Topics/Work-design/Hazardous-substances/Assessment-unit-biocides/Sprayexpo.html
SprayExpo model 2. Dermal only2. Market phase3. Buisness case4. Biocideshttps://www.baua.de/DE/Angebote/Publikationen/Berichte/F2137.pdf?__blob=publicationFile&v=2
SprayExpo model 4. R&D
SprayExpo model 5. validation
SprayExpo model 6. Launch
SprayExpo model 3. Regulatory phase7. Monitoring
British Aerosol Manufacturers Association indoor air modelBritish Aerosol Manufacturers Association (BAMA)2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Worker1. Chemical substances3. Liquid dispersion6. N/A3. Quantitativehttps://www.bama.co.uk/product.php?product_id=11
British Aerosol Manufacturers Association indoor air model2. Dermal only2. Market phase3. Consumer4. Biocides
British Aerosol Manufacturers Association indoor air model3. Regulatory phase
NANOSOLUTIONSFIOH1. Yes2. Risk Screening2. Hazard assessmentN/A1. Design phase2. Worker1. Chemical substancesN/A6. N/A2. Semi-quantitativehttp://nanosolutionsfp7.com/publications/publications/
NANOSOLUTIONS3. Consumer2. Cosmetic products
NANOSOLUTIONS4. General population3. Medical devices
NANOSOLUTIONS4. Biocides
NANOSOLUTIONS5. Food contact materials
NANOSOLUTIONS6. Food labelling
NANOSOLUTIONS7. Drugs
ESIG-EGRETEuropean Solvents Industry Group (ESIG)2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase3. Consumer1. Chemical substances3. Liquid dispersion6. N/A2. Semi-quantitativehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941027/pdf/jes2012128a.pdf
ESIG-EGRET6. Database2. Dermal only2. Market phase2. Cosmetic products
ESIG-EGRET3. Regulatory phase3. Medical deviceshttps://www.esig.org/reach-ges/consumers/
ESIG-EGRET4. Biocides
ESIG-EGRET5. Food contact materials
ESIG-EGRET6. Food labelling
ESIG-EGRET7. Drugs
ESIG-EGRET
SimpleBox4Nano screening fate assessment modelRIVM1. Yes5. Numerical estimate1. Release/exposure assessment5. Environmental3. Regulatory phase1. Environment1. Chemical substances1. Powdered spherical particulate2. 2-2.93. QuantitativeSimpleBox4nano is a regulatory-relevant multimedia fate model that is specifically fit for use with nanomaterials. The tool predicts background concentrations of nanomaterials in air, water, sediment and soil using nested regional, continental and global scale compartments.
SimpleBox4Nano screening fate assessment model8. Environmental fate4. Biocides
SimpleBox4Nano screening fate assessment model
SimpleBox4Nano screening fate assessment model
SimpleBox4Nano screening fate assessment model5. Food contact materials
SimpleBox4Nano screening fate assessment model6. Food labelling
SimpleBox4Nano screening fate assessment model7. Drugs
SimpleBox4Nano screening fate assessment model
SUNDSUniversita Ca' Foscari Venezia1. Yes2. Risk Screening3. Risk assessment (hazard and exposure)4. All routes1. Design phase1. Idea1. Environment1. Chemical substances1. Powdered spherical particulate2. 2-2.91. Qualitativehttps://cordis.europa.eu/docs/results/604/604305/final1-sun-final-report-20170525.pdf
SUNDS3. Life cycle assessment4. Risk-benefit analysis2. Market phase2. Screening2. Worker2. Cosmetic products2. Powdered non-spherical particulate3. Quantitative
SUNDS5. Numerical estimate5. Social impact assessment3. Regulatory phase3. Buisness case3. Consumer3. Medical devices3. Liquid dispersion
SUNDS6. Economic impact assessment4. R&D4. General population4. Biocides4. Solid reinforced composite
SUNDS5. validation5. Food contact materials
SUNDS6. Launch6. Food labelling
SUNDS7. Monitoring7. Drugs
SUNDS
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)ARA (Applied research associates)3. Partly5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeComputational particle dosimetry model for airborne particles that can be used for estimating human and test animal airway particle dosimetry. The model is applicable to risk assessment, research, and education. The MPPD model calculates the deposition and clearance of monodisperse and polydisperse aerosols in the respiratory tracts of rats and human adults and children (deposition only) for particles ranging in size from ultrafine (0.01 µm) to coarse (20 µm). The models are based on single-path and multiple-path methods for tracking air flow and calculating aerosol deposition in the lung. The single-path method calculates deposition in a typical path per airway generation, while the multiple-path method calculates particle deposition in all airways of the lung and provides lobar-specific and airway-specific information. Within each airway, deposition is calculated using theoretically derived efficiencies for deposition by diffusion, sedimentation, and impaction within the airway or airway bifurcation. Filtration of aerosols by the nose and mouth is determined using empirical efficiency functions. The MPPD model includes calculations of particle clearance in the lung following deposition.
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)2. Market phase3. Consumer2. Cosmetic products2. Powdered non-spherical particulate
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)3. Regulatory phase4. General population3. Medical devices3. Liquid dispersionhttp://www.ara.com/products/mppd.htm
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)4. Biocides4. Solid reinforced composite
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)5. Food contact materials
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)6. Food labelling
Multiple-Path Particle Dosimetry Model (MPPD v 3.04)7. Drugs
Dynamic probabilistic material flow model (DP-MFA)EMPA1. Yes5. Numerical estimate1. Release/exposure assessment5. Environmental3. Regulatory phase1. Environment1. Chemical substances1. Powdered spherical particulate4. 4-4.93. QuantitativeA DPMFA modeling framework combining dynamic material flow modeling with probabilistic modeling. Material transfers that lead to particular environmental stocks are represented as systems of mass-balanced flows. The time-dynamic behavior of the system is calculated by adding up the flows over several consecutive periods, considering changes in the inflow to the system and intermediate delays in local stocks. Incomplete parameter knowledge is represented and propagated using Bayesian modeling. The method is implemented as a simulation framework in Python to support experts from different domains in the development of their application models.
Dynamic probabilistic material flow model (DP-MFA)2. Cosmetic products2. Powdered non-spherical particulate
Dynamic probabilistic material flow model (DP-MFA)3. Medical devices3. Liquid dispersionhttps://pypi.python.org/pypi/dpmfa-simulator
Dynamic probabilistic material flow model (DP-MFA)4. Biocides4. Solid reinforced composite
Dynamic probabilistic material flow model (DP-MFA)5. Food contact materials
Dynamic probabilistic material flow model (DP-MFA)6. Food labelling
Dynamic probabilistic material flow model (DP-MFA)7. Drugs
NanoDUFLOWWageingen University & Research (WUR)1. Yes5. Numerical estimate8. Environmental fate5. Environmental3. Regulatory phase1. Environment1. Chemical substances1. Powdered spherical particulate5. = 53. QuantitativeNanoDUFLOW is a spatially resolved hydrological ENP fate model, that was validated using measurements of inert particulates.
NanoDUFLOW4. Biocides
NanoDUFLOW
NanoDUFLOW
DF4nanoGroupingECETOC1. Yes4. Framework2. Hazard assessment1. Inhalation only3. Regulatory phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A1. QualitativeA decision analytical tool to facilitate the grouping of NMs for the purpose of read-across for RA was proposed by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) ”Nano Task Force”. The tool consists of 3 tiers to assign NMs to 4 main groups: i) soluble NMs, ii) biopersistent high aspect ratio NMs, iii) passive NMs, and iv) active NMs. The tool performs sub-grouping within the main groups to determine and refine nanospecific information needs. The DF4nanoGrouping approach covers all relevant aspects of NM life cycles and biological pathways such as intrinsic material and system-dependent properties, biopersistence, uptake and biodistribution, cellular and apical toxic effects. Use, release and route of exposure are applied as 'qualifiers' in order to determine if the NM can be released from a product matrix; if not, the tool could suggest waiving of irrelevant testing. One distinguishing nanospecific feature of DF4nanoGrouping is that it groups NMs by their specific modes of action that result in apical toxic effects.
DF4nanoGrouping3. Consumer2. Cosmetic products2. Powdered non-spherical particulate
DF4nanoGrouping4. General population3. Liquid dispersionhttp://www.ecetoc.org/topics/nanotechnology/
DF4nanoGrouping4. Solid reinforced composite
ISO/TS 12901-2:2014 Nanotechnologies ISO1. Yes7. Guidance document3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase1. Idea2. Worker1. Chemical substances1. Powdered spherical particulate3. 3-3.92. Semi-quantitativeISO/TS 12901-2:2014 Nanotechnologies - Occupational risk management applied to engineered nanomaterials - Part 2: Use of the control banding approach
Occupational risk management applied to engineered nanomaterials 3. Regulatory phase2. Screening2. Powdered non-spherical particulate
Part 2: Use of the control banding approach3. Buisness case3. Liquid dispersionhttps://www.iso.org/standard/53375.html
4. R&D4. Solid reinforced composite
Bayesian NetworksNanoNextNL1. Yes2. Risk Screening2. Hazard assessment4. All routes1. Design phase2. Worker1. Chemical substances6. N/A3. QuantitativeA Bayesian Network (BN) for the prediction of the hazard potential and biological effects with the focus on metal- and metal-oxide NMs to support human health risk assessment. The developed BN captures the (inter)relationships between the exposure route, the NMs' physicochemical properties and the ultimate biological effects in a holistic manner and was based on international expert consultation and the scientific literature (e.g., in vitro/in vivo data). The BN was validated with independent data extracted from published studies and the accuracy of the prediction of the nanomaterials hazard potential was 72% and for the biological effect 71%, respectively. It is demonstrated that the BN may be used by different stakeholders at several stages in the risk assessment to predict certain properties of NMs of which little information is available or to prioritize NMs for further screening.
Bayesian Networks5. Numerical estimate2. Market phase3. ConsumerMarvin HJP, Bouzembrak Y, Janssen EM, van der Zande M, Murphy F, Sheehan B, Mullins M, Bouwmeester H, 2017. Application of Bayesian networks for hazard
Bayesian Networks3. Regulatory phase4. General population
Nano Species Sensitivity Weighted Distribution (n-SSWD) Department of Environmental Sciences, Informatics, and Statistics, University Ca’ Foscari, Venice1. Yes5. Numerical estimate2. Hazard assessment5. Environmental1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeAn approach to the ecological risk assessment of engineered NMs is proposed that can operate in the context of high uncertainty. This approach further develops species sensitivity weighted distribution (SSWD) by including three weighting criteria (species relevance, trophic level abundance, and nanotoxicity data quality) to address nanospecific needs.
Nano Species Sensitivity Weighted Distribution (n-SSWD)2. Market phase2. Cosmetic products2. Powdered non-spherical particulateSemenzin E, Lanzellotto E, Hristozov D, Critto A, Zabeo A, Giubilato E, Marcomini A, 2015. Species sensitivity weighted distribution for ecological risk assessment of engineered nanomaterials: The n-TiO2 case study. Environmental Toxicology and Chemistry 34 (11): 2644–2659, DOI: 10.1002/etc.3103
Nano Species Sensitivity Weighted Distribution (n-SSWD)3. Regulatory phase3. Medical devices3. Liquid dispersion
Nano Species Sensitivity Weighted Distribution (n-SSWD)4. Biocides4. Solid reinforced composite
Nano Species Sensitivity Weighted Distribution (n-SSWD)5. Food contact materials
Nano Species Sensitivity Weighted Distribution (n-SSWD)6. Food labelling
Nano Species Sensitivity Weighted Distribution (n-SSWD)7. Drugs
NanoProteinCorona (Enalos platform)NanoMILE / NovaMechanics Ltd1. Yes8. Guidance tool2. Hazard assessment4. All routes3. Regulatory phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeA predictive model for the assessment of the biological response of surface-modified gold NPs in the form of cellular association, including both internalized and surface-attached NPs, based on their physicochemical properties and protein corona fingerprints. A dataset of 105 unique NPs was used for developing the model. Cellular association is relevant to inflammatory responses, biodistribution, and toxicity in vivo. The validated predictive model is can be used as part of a regulatory or NP safe-by-design decision support system. This online tool allows the virtual screening of NPs to identify those that warrant further toxicity testing on the basis of predicted NP cellular association. https://www.tandfonline.com/doi/full/10.1080/17435390.2018.1504998
NanoProteinCorona (Enalos platform)5. numerical estimate2. WorkerAfantitis A, Melagraki G, Tsoumanis A, Valsami-Jones E, Lynch I, 2018. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints. Nanotoxicology 12 (10): 1148‒1165, DOI: 10.1080/17435390.2018.1504998
NanoProteinCorona (Enalos platform)3. Consumer
NanoProteinCorona (Enalos platform)4. General populationhttp://enalos.insilicotox.com/NanoProteinCorona/
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform)NanoMILE / NovaMechanics Ltd1. Yes5. Numerical estimate2. Hazard assessment4. All routes3. Regulatory phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeA predictive classification model for the toxicological assessment of iron oxide nanoparticles with different core, coating and surface modification based on a number of different properties including size, relaxivities, zeta potential and type of coating. The model successfully fulfilled the criteria recommended by the OECD for model validation, i.e. was validated both internally and externally in terms of goodness-of-fit, robustness and predictivity (see Publication).
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform)3. Risk assessment and/or management (hazard and exposure)3. Consumer2. Powdered non-spherical particulateLynch I, Afantitis A, Leonis G, Melagraki G, Valsami-Jones E, 2017. Strategy for Identification of Nanomaterials’ Critical Properties Linked to Biological Impacts: Interlinking of Experimental and Computational Approaches. In: Roy K. (eds) Advances in QSAR Modeling. Challenges and Advances in Computational Chemistry and Physics, vol 24. Springer, Cham, pp. 385‒424 Melagraki G, Afantitis A, 2015. A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform. Current Topics in Medicinal Chemistry 15(18): 1827‒1836, DOI: 10.2174/1568026615666150506144536
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform)4. General populationhttp://www.insilicotox.com/index.php/products/predictive-models-web-services/risk-assessment-tool-for-the-virtual-screening-of-nps/
nano-lazareNanoMapper1. Yes4. Framework2. Hazard assessment4. All routes1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/Anano-lazar is a modular framework for read-across predictions of chemical toxicities. Within the eNanoMapper project, lazar was extended with capabilities to handle nanomaterial data, interfaces to other eNanoMapper services (databases from data.enanomapper.net and ontologies) and a stable and user-friendly graphical interface for nanoparticle read-across predictions.
nano-lazar2. Market phase2. Worker2. Powdered non-spherical particulateHelma C, Rautenberg M, Gebele D, 2017. Nano-Lazar: Read across Predictions for Nanoparticle Toxicities with Calculated and Measured Properties. Front. Pharmacol. 8: 377, DOI: 10.3389/fphar.2017.00377
nano-lazar3. Regulatory phase3. Consumer3. Liquid dispersionhttps://www.enanomapper.net/modelling
nano-lazar4. General populationhttps://nano-lazar.in-silico.ch/
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)Pacific Northwest National Laboratory and for Nano applications: Harvard University (prof. Philip Demokritou)3. Partly5. Numerical estimate2. Hazard assessment4. All routes1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeA computational model to assess the biological effective dose of particles in in vitro systems. The model makes it possible to calculate the per area mass, surface area, and number of particles, as well as the fraction of total suspended material deposited as a function of time. This provides a ground-breaking improvement in dosimetry accuracy and enabled meaningful hazard rankings among NMs. The ISDD software (see Link) is available as code (requiring Matlab) and as a Windows executable file. Adaptations for nanoparticles have been also published (see Publications).
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)2. Market phase2. Worker2. Cosmetic productsHinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG, 2010. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7(1): 36, DOI: 10.1186/1743-8977-7-36
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)3. Regulatory phase3. Consumer3. Medical devicesCohen JM, Teeguarden JG, Demokritou P, 2014. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol 11: 20, DOI: 10.1186/1743-8977-11-20
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)4. BiocidesDeLoid GM, Cohen JM, Pyrgiotakis G, Pirela SV, Pal A, Liu J, Srebric J, Demokritou P, 2015. Advanced computational modeling for in vitro nanomaterial dosimetry. Part Fibre Toxicol 12: 32, DOI: 10.1186/s12989-015-0109-1
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)5. Food contact materialsCohen JM, DeLoid GM, Demokritou P, 2015. A critical review of in vitro dosimetry for engineered nanomaterials. Nanomedicine 10(19): 3015‒3032, DOI: 10.2217/nnm.15.129
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)6. Food labelling
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD)7. Drugshttp://nanodose.pnnl.gov/
Nano-QRA1. Yes6. Database/management2. Hazard assessment4. All routes1. Design phaseN/A1. Chemical substances1. Powdered spherical particulate6. N/A3. QuantitativeA quantitative read-across approach for NMs that addresses and overcomes a basic limitation of existing methods with a simple and effective algorithm for filling data gaps in quantitative manner, providing predictions of the missing data. It is based on one-point-slope, two-point formula, or the equation of a plane passing through three points.
Nano-QRA7. Guidance document7. Material characterization2. Powdered non-spherical particulate
Nano-QRA3. Liquid dispersionGajewicz A, Jagiello K, Cronin MTD, Leszczynskic J, Puzyn T, 2017. Addressing a bottle neck for regulation of nanomaterials: quantitative read-across (Nano-QRA) algorithm for cases when only limited data is available. Environ Sci: Nano 4, 346‒358, DOI: 10.1039/C6EN00399K
ConsexpoRIVM2. No2. Risk Screening1. Release/exposure assessment4. All routes1. Design phase2. Screening3. Consumer1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.rivm.nl/en/consexpo
Consexpo5. Numerical estimate2. Market phase3. Buisness case2. Cosmetic products2. Powdered non-spherical particulate
Consexpo3. Regulatory phase4. R&D4. Biocides
Consexpo5. validation
Consexpo6. Launch
Consexpo7. Monitoring
Consexpo5. Food contact materials
MEASEEBRC2. No5. Numerical estimate1. Release/exposure assesment1. Inhalation only3. Regulatory phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.ebrc.de/industrial-chemicals-reach/projects-and-references/mease.php
MEASE2. Powdered non-spherical particulate
MEASE3. Liquid suspension
MEASE
ENAE CPSCNIST1. Yes5. Numerical estimate1. Release/exposure assessment1. Inhalation only2. Market phase2. Screening2. Worker1. Chemical substances1. Powdered spherical particulate2. 2-2.93. Quantitativehttps://pages.nist.gov/CONTAM-apps/webapps/NanoParticleTool/index.htm
ENAE CPSC2. Dermal only3. Buisness case
ENAE CPSC4. R&D
ENAE CPSC5. validation
ENAE CPSC6. Launch
ENAE CPSC7. Monitoring3. Consumer2. Powder non-spherical particulate
EMKG Expo toolBAuA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A2. Semi-quantitativehttps://www.baua.de/EN/Service/Publications/Guidance/EMKG-Expo-Tool-2.html
EMKG Expo tool2. Market phase2. Powdered non-spherical particulate
EMKG Expo tool3. Regulatory phase3. Liquid suspension
CEMEPA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only2. Market phase3. Consumer1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.epa.gov/tsca-screening-tools/cem-consumer-exposure-model-download-and-install-instructions
CEM2. Dermal only2. Powdered non-spherical particulate
CEM3. Ingestion only3. Liquid suspension
ChemSTEEREPA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.epa.gov/tsca-screening-tools/chemsteer-chemical-screening-tool-exposures-and-environmental-releases
ChemSTEER2. Dermal only2. Market phase2. Worker2. Powdered non-spherical particulate
ChemSTEER3. Regulatory phase3. Liquid suspension
E-FASTEPA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only1. Design phase1. Environment1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitativehttps://www.epa.gov/tsca-screening-tools/e-fast-exposure-and-fate-assessment-screening-tool-version-2014
E-FAST8. Environmental fate2. Dermal only2. Market phase2. Worker2. Powdered non-spherical particulate
E-FAST3. Ingestion only3. Regulatory phase3. Consumer3. Liquid suspension
E-FAST4. General population
WPEMEPA2. No5. Numerical estimate1. Release/exposure assessment1. Inhalation only2. Market phase2. Worker1. Chemical substances3. Liquid suspension6. N/A3. Quantitativehttps://www.epa.gov/tsca-screening-tools/wpem-wall-paint-exposure-model-questions-and-answers
WPEM3. Consumer
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section)ITENE1. Yes5. Numerical estimate3. Risk assessment (hazard and exposure)4. All routes1. Design phase1. Idea1. Environment1. Chemical substances1. Powdered spherical particulate3. Quantitativehttps://sunds.gd/biorima/biorimaSelection
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section)2. Market phase2. Screening2. Worker3.Medical devices3. Liquid disperion1. 1-1.9
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section)3. Regulatory phase3. Buisness case
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section)4. R&D
StoffenmanagerCosanta BV2. No5. Numerical estimate3. Risk assessment (hazard and exposure)1. Inhalation only1. Design phase1. Idea2. Worker1. Chemical substances1. Powdered spherical particulate6. N/A3. Quantitative
Stoffenmanager2. Market phase2. Screening3. Liquid dispersion
Stoffenmanager3. Regulatory phase3. Buisness case
Stoffenmanager4. R&D
Stoffenmanager5. validation
Stoffenmanager6. Launch